5/19/22 07:31 | 5/17/22 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Fridriksdottir Hafrun | L3 | O | EVP,Glob | S | -1,068 | 8.22 | 0 | -130 | -99 | 1 | D | | | | | | | | | | | | | | |
3/8/22 16:07 | 3/4/22 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Fridriksdottir Hafrun | L3 | O | EVP,Glob | M.dm | 0 | 0.00 | 0 | 94 | 295 | 126 | D | | | | | | | | | | | | | | |
3/8/22 16:07 | 3/4/22 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Fridriksdottir Hafrun | L3 | O | EVP,Glob | S.dm | -250 | 7.45 | 0 | -34 | -21 | 126 | D | | | | | | | | | | | | | | |
3/2/22 07:47 | 2/28/22 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Fridriksdottir Hafrun | L3 | O | EVP,Glob | M.d | 0 | 0.00 | 0 | 22 | 49 | 66 | D | | | | | | | | | | | | | | |
3/2/22 07:47 | 2/28/22 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Fridriksdottir Hafrun | L3 | O | EVP,Glob | S.d | -62 | 8.14 | 0 | -8 | -10 | 66 | D | | | | | | | | | | | | | | |
2/10/22 16:09 | 2/9/22 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Fridriksdottir Hafrun | L3 | O | EVP,Glob | M.d | 0 | 0.00 | 0 | 16 | 46 | 51 | D | | | | | | | | | | | | | | |
2/10/22 16:09 | 2/9/22 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Fridriksdottir Hafrun | L3 | O | EVP,Glob | S.d | -55 | 9.06 | 0 | -6 | -11 | 51 | D | | | | | | | | | | | | | | |
8/12/21 16:04 | 8/10/21 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Fridriksdottir Hafrun | L3 | O | EVP,Glob | S | -506 | 9.95 | 0 | -51 | -55 | 41 | D | | | | | | | | | | | | | | |
5/13/21 07:45 | 5/11/21 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Fridriksdottir Hafrun | L3 | O | EVP,Glob | M.d | 0 | 0.00 | 0 | 38 | 70 | 92 | D | | | | | | | | | | | | | | |
5/13/21 07:45 | 5/11/21 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Fridriksdottir Hafrun | L3 | O | EVP,Glob | S.d | -195 | 10.22 | 0 | -19 | -17 | 92 | D | | | | | | | | | | | | | | |
3/8/21 16:07 | 3/4/21 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Fridriksdottir Hafrun | L3 | O | EVP,Glob | M.d | 0 | 0.00 | 0 | 19 | 35 | 73 | D | | | | | | | | | | | | | | |
3/8/21 16:07 | 3/4/21 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Fridriksdottir Hafrun | L3 | O | EVP,Glob | S.d | -101 | 10.57 | 0 | -10 | -11 | 73 | D | | | | | | | | | | | | | | |
3/4/21 16:03 | 3/2/21 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Fridriksdottir Hafrun | L3 | O | EVP,Glob | S | -541 | 10.82 | 0 | -50 | -44 | 64 | D | | | | | | | | | | | | | | |
3/2/21 16:05 | 2/28/21 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Fridriksdottir Hafrun | L3 | O | EVP,Glob | M.d | 0 | 0.00 | 0 | 22 | 23 | 114 | D | | | | | | | | | | | | | | |
3/2/21 16:05 | 3/1/21 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Fridriksdottir Hafrun | L3 | O | EVP,Glob | S.d | -118 | 10.83 | 0 | -11 | -9 | 114 | D | | | | | | | | | | | | | | |
2/17/21 16:07 | 2/14/21 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Fridriksdottir Hafrun | L3 | O | EVP,Glob | M.d | 0 | 0.00 | 0 | 5 | 5 | 103 | D | | | | | | | | | | | | | | |
2/17/21 16:07 | 2/16/21 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Fridriksdottir Hafrun | L3 | O | EVP,Glob | S.d | -23 | 11.12 | 0 | -2 | -2 | 103 | D | | | | | | | | | | | | | | |
2/11/21 16:05 | 2/9/21 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Fridriksdottir Hafrun | L3 | O | EVP,Glob | M.d | 0 | 0.00 | 0 | 16 | 19 | 100 | D | | | | | | | | | | | | | | |
2/11/21 16:05 | 2/9/21 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Fridriksdottir Hafrun | L3 | O | EVP,Glob | S.d | -374 | 12.69 | 0 | -29 | -23 | 100 | D | | | | | | | | | | | | | | |
3/19/20 07:33 | 3/17/20 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Fridriksdottir Hafrun | L3 | O | EVP,Glob | M.d | 0 | 0.00 | 0 | 1 | 2 | 46 | D | | | | | | | | | | | | | | |
3/19/20 07:33 | 3/17/20 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Fridriksdottir Hafrun | L3 | O | EVP,Glob | S.d | -4 | 7.16 | 0 | -1 | -1 | 46 | D | | | | | | | | | | | | | | |
2/18/20 07:23 | 2/14/20 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Fridriksdottir Hafrun | L3 | O | EVP,Glob | M.d | 0 | 0.00 | 0 | 23 | 106 | 45 | D | | | | | | | | | | | | | | |
2/18/20 07:23 | 2/14/20 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Fridriksdottir Hafrun | L3 | O | EVP,Glob | S.d | -139 | 12.14 | 0 | -11 | -20 | 45 | D | | | | | | | | | | | | | | |
2/11/20 06:57 | 2/9/20 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Fridriksdottir Hafrun | L3 | O | EVP,Glob | M.d | 0 | 0.00 | 0 | 16 | 94 | 33 | D | | | | | | | | | | | | | | |
2/11/20 06:57 | 2/10/20 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Fridriksdottir Hafrun | L3 | O | EVP,Glob | S.d | -68 | 12.27 | 0 | -6 | -14 | 33 | D | | | | | | | | | | | | | | |
1/2/20 06:08 | 12/31/19 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Fridriksdottir Hafrun | L3 | O | EVP,Glob | M.d | 0 | 0.00 | 0 | 5 | 26 | 23 | D | | | | | | | | | | | | | | |
1/2/20 06:08 | 12/31/19 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Fridriksdottir Hafrun | L3 | O | EVP,Glob | S.d | -24 | 9.92 | 0 | -2 | -10 | 23 | D | | | | | | | | | | | | | | |
12/3/19 06:32 | 11/30/19 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Fridriksdottir Hafrun | L3 | O | EVP,Glob | M.d | 0 | 0.00 | 0 | 8 | 65 | 21 | D | | | | | | | | | | | | | | |
12/3/19 06:32 | 12/2/19 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Fridriksdottir Hafrun | L3 | O | EVP,Glob | S.d | -45 | 10.49 | 0 | -4 | -17 | 21 | D | | | | | | | | | | | | | | |
3/19/19 08:04 | 3/17/19 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Fridriksdottir Hafrun | L3 | O | EVP,Glob | M.d | 0 | 0.00 | 0 | 1 | 6 | 17 | D | | | | | | | | | | | | | | |
3/19/19 08:04 | 3/18/19 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Fridriksdottir Hafrun | L3 | O | EVP,Glob | S.d | -6 | 16.63 | 0 | 0 | -2 | 17 | D | | | | | | | | | | | | | | |
3/5/19 07:16 | 3/4/19 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Fridriksdottir Hafrun | L3 | O | EVP,Glob | M.d | 0 | 0.00 | 0 | 1 | 8 | 16 | D | | | | | | | | | | | | | | |
3/5/19 07:16 | 3/4/19 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Fridriksdottir Hafrun | L3 | O | EVP,Glob | S.d | -7 | 16.88 | 0 | 0 | -2 | 16 | D | | | | | | | | | | | | | | |
2/19/19 07:11 | 2/14/19 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Fridriksdottir Hafrun | L3 | O | EVP,Glob | M.d | 0 | 0.00 | 0 | 5 | 54 | 15 | D | | | | | | | | | | | | | | |
2/19/19 07:11 | 2/14/19 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Fridriksdottir Hafrun | L3 | O | EVP,Glob | S.d | -33 | 17.67 | 0 | -2 | -11 | 15 | D | | | | | | | | | | | | | | |
1/3/19 07:24 | 12/31/18 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Fridriksdottir Hafrun | L3 | O | EVP,Glob | M.d | 0 | 0.00 | 0 | 5 | 65 | 12 | D | | | | | | | | | | | | | | |
1/3/19 07:24 | 1/2/19 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Fridriksdottir Hafrun | L3 | O | EVP,Glob | S.d | -26 | 15.70 | 0 | -2 | -12 | 12 | D | | | | | | | | | | | | | | |
12/4/18 08:09 | 11/30/18 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Fridriksdottir Hafrun | L3 | O | EVP,Glob | M.d | 0 | 0.00 | 0 | 3 | 44 | 9 | D | | | | | | | | | | | | | | |
12/4/18 08:09 | 11/30/18 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Fridriksdottir Hafrun | L3 | O | EVP,Glob | S.d | -20 | 21.76 | 0 | -1 | -10 | 9 | D | | | | | | | | | | | | | | |
3/20/18 16:07 | 3/17/18 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Fridriksdottir Hafrun | L3 | O | EVP,Glob | M.d | 0 | 0.00 | 0 | 1 | 17 | 7 | D | | | | | | | | | | | | | | |
3/20/18 16:07 | 3/19/18 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Fridriksdottir Hafrun | L3 | O | EVP,Glob | S.d | -6 | 17.88 | 0 | 0 | -5 | 7 | D | | | | | | | | | | | | | | |
3/6/18 16:12 | 3/4/18 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Fridriksdottir Hafrun | L3 | O | EVP,Glob | M.dm | 0 | 0.00 | 0 | 5 | 257 | 6 | D | | | | | | | | | | | | | | |
10/2/13 21:03 | 9/30/13 | ACT | Actavis, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Fridriksdottir Hafrun | NJ | O | SVP,Glob | M.d | 0 | 0.00 | 0 | 5 | | 0 | D | | | | | | | | | | | | | | |